Memantine hydrochloride is a raw material. It should be prescribed by experienced doctors in the diagnosis and treatment of Alzheimer's dementia and guided by patients. Treatment can only begin when there are caregivers around the patient who regularly supervise the patient's medication. Dementia should be diagnosed in accordance with current diagnostic criteria and guidelines.
Memantine is a medication used to treat moderate-to-severe Alzheimer's disease. It is less preferred than acetylcholinesterase inhibitors such as donepezil. Treatment should only be continued if beneficial effects are seen. It is taken by mouth.
Memantine was approved for medical use in the United States in 2003. It is available as a generic medication. In 2017, it was the 149th most commonly prescribed medication in the United States, with more than four million prescriptions
Memantine is clinically used for the treatment of moderate to severe senile dementia and parkinsonism syndrome. It is a new type of anti-senile dementia drug and can be used for the treatment of moderate to severe senile dementia.
Memantine is used to treat moderate-to-severe Alzheimer's disease, especially for people who are intolerant of or have a contraindication to AChE (acetylcholinesterase) inhibitors.One guideline recommends memantine or an AChE inhibitor be considered in people in the early-to-mid stage of dementia.
Memantine has been associated with a modest improvement; with small positive effects on cognition, mood, behavior, and the ability to perform daily activities in moderate-to-severe Alzheimer's disease. There does not appear to be any benefit in mild disease.
Memantine when added to donepezil in those with moderate-to-severe dementia resulted in "limited improvements" in a 2017 review. The UK National Institute of Clinical Excellence (NICE) issued guidance in 2018 recommending consideration of the combination of memantine with donepezil in those with moderate-to-severe dementia. Effects in autism are unclear. Recent scientific journal reports are showing guarded promise with severe obsessive compulsive disorder.
Kami adunay daghang mga de-kalidad nga pabrika nga adunay lawom nga kooperasyon, nga makahatag kanimo og taas nga kalidad nga mga produkto ug mga presyo sa kompetisyon. Ug makahatag usab kami og mga diskwento alang sa dinaghan nga pagpalit.Ug kami nakigtambayayong sa daghang mga propesyonal nga kompanya sa pagpasa sa kargamento, makahatud sa mga produkto nga luwas ug hapsay sa imong mga kamot. Delivery panahon mao ang mahitungod sa 3-20 ka adlaw human sa pagkumpirma sa pagbayad.
butang |
Requirements |
Test Results |
appearance |
White or almost white crystalline powder |
White crystalline powder |
Pag-ila |
IR |
Comply |
Related substance |
1-methyladamantane ≤0.3% 1,3,5 -trimethyladamantane ≤0.3% Unknow impuritiy ≤0.1% Total impurity ≤0.5% |
0.13% 0.14% <0.1% <0.4% |
Ang nahabilin sa ignition |
≤0.1% |
0.06% |
Heavy matal |
≤10ppm |
<10ppm |
Pagkawala sa pagpauga |
≤0.5% |
0.29% |
Pagsusi |
98.5-101.0% |
99.13% |
Residual Solvents |
Ethyl Acetat: ≤0.5% Ethanol: ≤0.5% |
0.08% 0.12% |
PH |
4.5-5.5 |
5.3 |
Microbial Limits |
Max 5*102 aerobes and fungl per 1g E. Coli: Negative Salmonella: Negative
|
Pass |
Size of distributed particles |
Pass 100μ m |
Nagpahiuyon |
Konklusyon |
Meet the requirements |
Memantine is a medication used to treat moderate-to-severe Alzheimer's disease. It is less preferred than acetylcholinesterase inhibitors such as donepezil. Treatment should only be continued if beneficial effects are seen. It is taken by mouth.
Memantine was approved for medical use in the United States in 2003. It is available as a generic medication. In 2017, it was the 149th most commonly prescribed medication in the United States, with more than four million prescriptions
Memantine HCl is the HCl form of Memantine. Memantine is a well- known neuroprotective drug used for the treatment of Alzheimer's disease. It is believed to be the first neuroprotective drug that has achieve clinical approval by US FDA as well as European.
The development of Alzheimer's disease involves the misfolded mutant proteins such as β-amyloid peptide (Aβ, particularly Aβ1−42). These misfolded mutant protein can increase the NMDA response and further cause severe excitotoxicity.
Memantine suppresses this process through acting as the antagonist of the N-methyl-d- aspartate-sensitive glutamate receptor (NMDARs).
Memantine is also under investigation as a potential treatment for other kind of neurodegenerative disorders such as HIV-associated dementia, neuropathic pain, glaucoma, depression, Huntington's disease, ALS and movement disorders, among other.
1. Ikaw ba usa ka pabrika o usa ka kompanya sa pamatigayon?
Kami usa ka compnay nga naghiusa sa industriya ug pamatigayon, nga naghatag ug one-stop service.OEM mahimong dawaton.
2. Naghatag ka ba og mga sampol? Libre ba kini o sobra?
Libre nga mga sample.Ang bayad sa kargamento sa sample kinahanglan nga ibayad sa imong kiliran.
3. Aduna ka bay mga sertipiko nga may kalabutan sa pagkontrol sa kalidad?
ISO 9001: 2008 nga sertipikasyon aron masiguro ang kalidad.
4. Unsa ang akong ihatag aron makakuha og kinutlo?
Pls ipahibalo kanamo ang tipo sa produkto nga imong gikinahanglan, gidaghanon sa pag-order, adres ug piho nga mga kinahanglanon. Ang kinutlo himuon alang sa imong pakisayran sa oras.
5. Unsa nga matang sa paagi sa pagbayad ang imong gusto? Unsang matanga sa mga termino ang gidawat?
Gidawat nga Delivery Terms: FOB, CFR, CIF, EXW;
Gidawat nga Bayad nga Salapi:USD;
Gidawat nga Uri sa Pagbayad: T / T, Western Union; Paypal, Trade Assurance.
Pinulongan nga Gisulti: English.
Mga kategoriya sa produkto